Dry Powder Inhalation (DPI) is a leading drug delivery technology for the treatment of respiratory diseases, as well as increasingly for systemic drug delivery. Optimizing a DPI capsule is not an easy task; understanding the relationship between the device, formulation and capsule is key to improve drug performances.This webinar provides insight into state-of-the-art technologies for inhalation drug development:Capsugel will share the unique know-how gained from more than 20 years of experience in specialized inhalation capsules.Bend Research, a division of Capsugel Dosage Form Solutions, will discuss expertise in formulation and particle engineering with spray drying technology.Aptar, a key player in capsule-based expedients, will describe how the capsule-based devices are a simple and cost-effective way to deliver medication via the pulmonary route, and why these types of devices are the future of inhalation technology.
Sr. Technical Group Lead
Bend Research, Capsugel Dosage Form Solutions
Director Polymer Science, Research & Development
Pharmaceutical Business Development Manager, EMEA
Director, Scientific Affairs, Aptar Pharma, Prescription Division, France